Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance therapy in non-small cell lung cancer.
Genestreti G, Di Battista M, Cavallo G, Bartolotti M, Brandes AA. Genestreti G, et al. Among authors: cavallo g. Expert Rev Anticancer Ther. 2015;15(7):839-46. doi: 10.1586/14737140.2015.1052410. Epub 2015 May 31. Expert Rev Anticancer Ther. 2015. PMID: 26027675 Review.
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G, Tiseo M, Kenmotsu H, Kazushige W, Di Battista M, Cavallo G, Carloni F, Bongiovanni A, Burgio MA, Casanova C, Metro G, Scarpi E, Korkmaz T, Selcuk S, Roopa K, Califano R. Genestreti G, et al. Among authors: cavallo g. Clin Lung Cancer. 2015 Nov;16(6):e223-8. doi: 10.1016/j.cllc.2015.04.006. Epub 2015 Apr 24. Clin Lung Cancer. 2015. PMID: 25983005
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma.
Genestreti G, de Biase D, Di Battista M, Cavallo G, Degli Esposti R, Visani M, Acquaviva G, Brand T, Pession A, Tallini G, Brandes AA. Genestreti G, et al. Among authors: cavallo g. Clin Lung Cancer. 2017 May;18(3):e215-e217. doi: 10.1016/j.cllc.2017.01.003. Epub 2017 Jan 11. Clin Lung Cancer. 2017. PMID: 28162944 No abstract available.
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.
de Biase D, Genestreti G, Visani M, Acquaviva G, Di Battista M, Cavallo G, Paccapelo A, Cancellieri A, Trisolini R, Degli Esposti R, Bartolini S, Pession A, Tallini G, Brandes AA. de Biase D, et al. Among authors: cavallo g. PLoS One. 2017 May 16;12(5):e0177822. doi: 10.1371/journal.pone.0177822. eCollection 2017. PLoS One. 2017. PMID: 28520821 Free PMC article.
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).
Brandes AA, Tosoni A, Cavallo G, Bertorelle R, Gioia V, Franceschi E, Biscuola M, Blatt V, Crinò L, Ermani M; GICNO. Brandes AA, et al. Among authors: cavallo g. Br J Cancer. 2006 Nov 6;95(9):1155-60. doi: 10.1038/sj.bjc.6603376. Epub 2006 Oct 3. Br J Cancer. 2006. PMID: 17024124 Free PMC article. Clinical Trial.
Is protracted low-dose temozolomide feasible in glioma patients?
Tosoni A, Cavallo G, Ermani M, Scopece L, Franceschi E, Ghimenton C, Gardiman M, Pasetto L, Blatt V, Brandes AA. Tosoni A, et al. Among authors: cavallo g. Neurology. 2006 Feb 14;66(3):427-9. doi: 10.1212/01.wnl.0000196465.83423.ec. Neurology. 2006. PMID: 16476947
410 results